glutamic acid has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, N; Blessington, D; Chance, B; Delikatny, EJ; Feldman, M; Glickson, JD; Jenkins, WT; Mancuso, A; Nelson, DS; Poptani, H | 1 |
| Akimoto, H; Itoh, F; Ootsu, K; Wajima, M; Yukishige, K | 1 |
2 other study(ies) available for glutamic acid and Fibrosarcoma
| Article | Year |
|---|---|
Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning.
Topics: Animals; Carbon Isotopes; Cell Division; Chromatography, High Pressure Liquid; Cyclophosphamide; Female; Fibrosarcoma; Glutamic Acid; Glycolysis; Ion-Selective Electrodes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Mitochondria; Mitosis; Neovascularization, Pathologic; Oxidation-Reduction; Oxygen; Oxygen Consumption; Ultrasonography | 2003 |
Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. I: Synthesis and biological properties of pyrrolo[2,3-d]pyrimidine antifolates containing tetrazole congener of glutamic acid.
Topics: Animals; Antineoplastic Agents; Cell Division; Fibrosarcoma; Folic Acid Antagonists; Glutamic Acid; Magnetic Resonance Spectroscopy; Methotrexate; Mice; Structure-Activity Relationship; Tetrazoles; Tumor Cells, Cultured | 1995 |